Zimmer Biomet Holdings ZBH Ratios & Valuation
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 70%+0.3pp | 69.7%-1.7pp | 71.4%+0.4pp | 71.1%0.0pp | 71.1%-0.4pp | |
| Operating margin | 14%+0.7pp | 13.3%-3.3pp | 16.6%+0.5pp | 16.1%-0.9pp | 17%+0.3pp | |
| Net margin | 9.1%+0.5pp | 8.6%-1.5pp | 10.1%-0.5pp | 10.5%-1.4pp | 11.9%+0.1pp | |
| EBITDA margin | 27.2%+0.6pp | 26.6%-3.4pp | 30%+0.7pp | 29.4%-0.8pp | 30.2%+0.5pp | |
| Free cash flow margin | 17.3%-0.6pp | 17.9%-0.6pp | 18.5%-0.3pp | 18.8%-0.2pp | 19%+2.1pp | |
| Returns | ||||||
| Return on equity | 6.1%+0.5pp | 5.6%-0.8pp | 6.4%-0.1pp | 6.5%-0.8pp | 7.3%+0.1pp | |
| Return on assets | 3.4%+0.2pp | 3.2%-0.4pp | 3.6%-0.1pp | 3.7%-0.5pp | 4.2%0.0pp | |
| Return on invested capital | 6.2%+0.5pp | 5.7%+0.2pp | 5.6%-0.1pp | 5.7%-0.6pp | 6.3%+0.2pp | |
| Efficiency | ||||||
| Asset turnover | 0.4×0.0× | 0.4×0.0× | 0.4×0.0× | 0.4×0.0× | 0.4×0.0× | |
| Inventory turnover | 1.1×0.0× | 1.1×+0.2× | 0.9×0.0× | 0.9×0.0× | 1×0.0× | |
| Liquidity | ||||||
| Current ratio | 1.7×-0.2× | 2×-0.4× | 2.4×+0.6× | 1.9×-0.6× | 2.4×+0.5× | |
| Quick ratio | 0.9×-0.1× | 1.1×-0.3× | 1.4×+0.4× | 1×-0.5× | 1.5×+0.5× | |
| Cash ratio | 0.1×-0.1× | 0.2×-0.3× | 0.5×+0.3× | 0.2×-0.4× | 0.6×+0.4× | |
| Leverage | ||||||
| Debt-to-equity | 0.6×0.0× | 0.6×0.0× | 0.6×0.0× | 0.6×0.0× | 0.6×+0.1× | |
| Debt-to-assets | 0.3×0.0× | 0.3×0.0× | 0.3×0.0× | 0.3×0.0× | 0.3×0.0× | |
| Net debt / EBITDA | 3.1×-0.2× | 3.3×+0.4× | 2.8×-0.2× | 3×+0.6× | 2.5×-0.1× | |
| Per Share | ||||||
| Book value per share | $64.73+1.3% | $63.90-0.4% | $64.17+1.6% | $63.16+1.8% | $62.07+1.5% | |
| Valuation | ||||||
| Market capitalization | $17.69B-0.7% | $17.82B-8.7% | $19.51B+6.8% | $18.27B-18.9% | $22.53B+7.1% | |
| Enterprise value | $24.74B-1.0% | $24.98B-5.1% | $26.33B+4.1% | $25.28B-10.7% | $28.32B+5.1% | |
| Price / earnings | 23.2×-2.0× | 25.3×+1.0× | 24.2×+2.0× | 22.2×-2.5× | 24.7×+1.4× | |
| Price / sales | 2.1×-0.1× | 2.2×-0.3× | 2.4×+0.1× | 2.3×-0.6× | 2.9×+0.2× | |
| Price / book | 1.4×0.0× | 1.4×-0.1× | 1.5×+0.1× | 1.5×-0.4× | 1.8×+0.1× | |
| EV / EBITDA | 10.8×-0.6× | 11.4×+0.5× | 10.9×0.0× | 11×-1.2× | 12.2×+0.4× | |
| EV / sales | 2.9×-0.1× | 3×-0.3× | 3.3×+0.1× | 3.2×-0.5× | 3.7×+0.2× | |
| Free cash flow yield | 8.2%0.0pp | 8.3%+0.7pp | 7.6%-0.4pp | 8.1%+1.6pp | 6.5%+0.3pp | |
| Earnings yield | 4.3%+0.3pp | 4%-0.2pp | 4.1%-0.4pp | 4.5%+0.5pp | 4.1%-0.2pp | |
| Dividend yield | 1.1%0.0pp | 1.1%+0.1pp | 1%-0.1pp | 1.1%+0.2pp | 0.9%-0.1pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Zimmer Biomet Holdings's profit margins?
- Zimmer Biomet Holdings (ZBH) runs a 70.0% gross margin and a 14.0% operating margin, with a 9.1% net margin.
- Where do Zimmer Biomet Holdings's ratios come from?
- Every ratio is computed from Zimmer Biomet Holdings's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
